Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MERCURY SYSTEMS INCMRCY · Entity 3908 | Director | May 26, 2026 | May 27, 2026 |
| Maxar Technologies Inc.MAXR · Entity 113823 | Director · President and CEO | January 01, 2019 | January 10, 2019 |
| New Vista Acquisition CorpNVSA · Entity 142588 | Director | February 16, 2021 | February 17, 2021 |
| STRYKER CORPSYK · Entity 369 | Director | March 21, 2014 | March 21, 2014 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MERCURY SYSTEMS INC
Report date May 26, 2026 · Filed May 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy The Howard L. Lance Revocable Living Trust Dated 9/1/2006 | 1,250 |
Reported balance
After 2026-05-26 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-05-26 · Sale · Disposed 8,000 · Balance 1,250 F1: This transaction was executed in multiple trades at prices ranging from $99.3600 to $100.4501. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| Common StockSEC Table I · non-derivative | IndirectBy The Howard L. Lance Revocable Living Trust Dated 9/1/2006 | 0 |
Reported balance
After 2026-05-26 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-05-26 · Sale · Disposed 1,250 · Balance 0 F2: This transaction was executed in multiple trades at prices ranging from $98.1000 to $98.9000. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| Common StockSEC Table I · non-derivative | Direct | 27,272 |
Reported balance
Holding disclosure · report date 2026-05-26 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 27,272 |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $99.3600 to $100.4501. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: This transaction was executed in multiple trades at prices ranging from $98.1000 to $98.9000. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Maxar Technologies Inc.
Report date January 01, 2019 · Filed January 10, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 176,221 |
Reported balance
Holding disclosure · report date 2019-01-01 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 176,221 F1: Amount reported includes 44,323 unvested Restricted Stock Units ("RSUs"), which were granted on December 14, 2017 and vest as follows: 22,161 shares vest on December 14, 2019 and 22,162 December 14, 2020. |
| Stock Appreciation Right - 2016 PlanSEC Table II · derivative / convertible security · Conversion / exercise price $69.78 · Expires 2021-05-01 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2019-01-01 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F2: Long Term Incentive Plan ("LTIP") Units awarded under the 2016 LTIP Plan ("2016 LTIP Plan") vest in thirds on the first, second, and third anniversaries of the date of grant. The maturity date of LTIP unit awards under the 2016 LTIP Plan is midnight on the fifth anniversary of the date of grant. |
| Stock Appreciation Right - 2017 PlanSEC Table II · derivative / convertible security · Conversion / exercise price $49.79 · Expires 2026-11-30 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2019-01-01 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance Not disclosed F3: LTIP Units awarded under the 2017 LTIP Plan vest in quarters on the first, second, third and fourth anniversaries of the date of grant. The maturity date of LTIP awards under the 2017 LTIP Plan is midnight on the tenth anniversary of the date of grant. |
| 2018 LTIP - Omnibus PlanSEC Table II · derivative / convertible security · Conversion / exercise price $66.03 · Expires 2027-12-31 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2019-01-01 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance Not disclosed F4: LTIP Units awarded under the Omnibus Equity Incentive Plan ("Omnibus Plan") vest in four equal annual installments beginning on the first anniversary of the date of grant. The maturity date of LTIP awards under the Omnibus Plan is midnight on the tenth anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Amount reported includes 44,323 unvested Restricted Stock Units ("RSUs"), which were granted on December 14, 2017 and vest as follows: 22,161 shares vest on December 14, 2019 and 22,162 December 14, 2020.
F2: Long Term Incentive Plan ("LTIP") Units awarded under the 2016 LTIP Plan ("2016 LTIP Plan") vest in thirds on the first, second, and third anniversaries of the date of grant. The maturity date of LTIP unit awards under the 2016 LTIP Plan is midnight on the fifth anniversary of the date of grant.
F3: LTIP Units awarded under the 2017 LTIP Plan vest in quarters on the first, second, third and fourth anniversaries of the date of grant. The maturity date of LTIP awards under the 2017 LTIP Plan is midnight on the tenth anniversary of the date of grant.
F4: LTIP Units awarded under the Omnibus Equity Incentive Plan ("Omnibus Plan") vest in four equal annual installments beginning on the first anniversary of the date of grant. The maturity date of LTIP awards under the Omnibus Plan is midnight on the tenth anniversary of the date of grant.
New Vista Acquisition Corp
Report date February 16, 2021 · Filed February 17, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B ordinary sharesSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-02-16 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: As described in the issuer's registration statement on Form S-1 (File No. 333-252622) under the heading "Description of Securities--Founder Shares," the Class B ordinary shares of the issuer, par value $0.0001 per share, will automatically convert into Class A ordinary shares of the issuer, par value $0.0001 per share, at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustments, and have no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: As described in the issuer's registration statement on Form S-1 (File No. 333-252622) under the heading "Description of Securities--Founder Shares," the Class B ordinary shares of the issuer, par value $0.0001 per share, will automatically convert into Class A ordinary shares of the issuer, par value $0.0001 per share, at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustments, and have no expiration date.
STRYKER CORP
Report date March 21, 2014 · Filed March 21, 2014
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,519 |
Reported balance
After 2014-03-21 transaction · row 1
1 source rowRow 1 · 2014-03-21 · Exercise / conversion · Acquired 1,380 · Balance 18,519 F1: On March 21, 2014, 1,380 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. |
| Common StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2014-03-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2014-03-21 · Exercise / conversion · Disposed 1,380 · Balance 0 F1: On March 21, 2014, 1,380 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: On March 21, 2014, 1,380 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Change Healthcare Inc.
Report date October 03, 2022 · Filed October 05, 2022
Section 16 reporting ended · disclosed 2022-10-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2022-10-03 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2022-10-03 · Disposition to issuer · Disposed 211,720 · Balance 14,794 F1: On October 3, 2022, UnitedHealth Group Incorporated ("UnitedHealth Group") acquired Change Healthcare Inc. (the "Issuer") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the "Merger Agreement") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the "Common Stock") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash (the "Merger Consideration"), without interest and less any applicable holding tax. Row 2 · 2022-10-03 · Disposition to issuer · Disposed 7,136 · Balance 7,658 F2: At the Effective Time of the Merger, all deferred stock units of the Issuer automatically vested and were automatically converted into UnitedHealth Group deferred stock units calculated by taking the merger consideration of $25.75 per share of Common Stock and dividing it by the volume weighted average of the closing sale prices per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date (the "Equity Award Exchange Ratio") and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer deferred stock units. Row 3 · 2022-10-03 · Disposition to issuer · Disposed 7,658 · Balance 0 F3: At the Effective Time of the Merger, all restricted stock units of the Issuer automatically vested and were automatically converted into United restricted stock units calculated by taking the merger consideration of $25.75 per share of Common Stock of the Issuer and dividing it by the Equity Award Exchange Ratio and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer restricted stock units. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.99 · Expires 2027-10-17 | Direct | 0 |
Reported balance
After 2022-10-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-10-03 · Disposition to issuer · Disposed 40,448 · Balance 0 F5: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option. F4: These options are fully vested. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.99 · Expires 2028-05-25 | Direct | 0 |
Reported balance
After 2022-10-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-10-03 · Disposition to issuer · Disposed 6,320 · Balance 0 F5: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option. F4: These options are fully vested. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.92 · Expires 2022-11-28 | Direct | 0 |
Reported balance
After 2022-10-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-10-03 · Disposition to issuer · Disposed 28,828 · Balance 0 F5: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option. F4: These options are fully vested. |
| Stock Appreciation rightSEC Table II · derivative / convertible security · Conversion / exercise price $0.38 · Expires 2023-05-22 | Direct | 0 |
Reported balance
After 2022-10-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2022-10-03 · Disposition to issuer · Disposed 45,758 · Balance 0 F6: These stock appreciation rights ("SARs") are fully vested. Pursuant to the Merger Agreement, the SARs were automatically converted into SARs of UnitedHealth Group, denominated in a number of shares of common stock of UnitedHealth Group equal to the product of the number of shares of Common Stock subject to the Issuer SARs multiplied by the Equity Award Exchange Ratio, at an exercise price per share equal to the strike price per share applicable to such SAR divided by the Equity Award Exchange Ratio. The UnitedHealth Group SARs will continue to be subject to the same terms and conditions as were applicable to the Issuer SARs. |
| Stock Appreciation rightSEC Table II · derivative / convertible security · Conversion / exercise price $0.38 · Expires 2022-11-28 | Direct | 0 |
Reported balance
After 2022-10-03 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2022-10-03 · Disposition to issuer · Disposed 11,439 · Balance 0 F6: These stock appreciation rights ("SARs") are fully vested. Pursuant to the Merger Agreement, the SARs were automatically converted into SARs of UnitedHealth Group, denominated in a number of shares of common stock of UnitedHealth Group equal to the product of the number of shares of Common Stock subject to the Issuer SARs multiplied by the Equity Award Exchange Ratio, at an exercise price per share equal to the strike price per share applicable to such SAR divided by the Equity Award Exchange Ratio. The UnitedHealth Group SARs will continue to be subject to the same terms and conditions as were applicable to the Issuer SARs. |
| Stock Appreciation rightSEC Table II · derivative / convertible security · Conversion / exercise price $8.07 · Expires 2023-05-22 | Direct | 0 |
Reported balance
After 2022-10-03 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2022-10-03 · Disposition to issuer · Disposed 149,685 · Balance 0 F6: These stock appreciation rights ("SARs") are fully vested. Pursuant to the Merger Agreement, the SARs were automatically converted into SARs of UnitedHealth Group, denominated in a number of shares of common stock of UnitedHealth Group equal to the product of the number of shares of Common Stock subject to the Issuer SARs multiplied by the Equity Award Exchange Ratio, at an exercise price per share equal to the strike price per share applicable to such SAR divided by the Equity Award Exchange Ratio. The UnitedHealth Group SARs will continue to be subject to the same terms and conditions as were applicable to the Issuer SARs. |
Filing footnotes · ownership attribution and instrument terms
F1: On October 3, 2022, UnitedHealth Group Incorporated ("UnitedHealth Group") acquired Change Healthcare Inc. (the "Issuer") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the "Merger Agreement") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the "Common Stock") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash (the "Merger Consideration"), without interest and less any applicable holding tax.
F2: At the Effective Time of the Merger, all deferred stock units of the Issuer automatically vested and were automatically converted into UnitedHealth Group deferred stock units calculated by taking the merger consideration of $25.75 per share of Common Stock and dividing it by the volume weighted average of the closing sale prices per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date (the "Equity Award Exchange Ratio") and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer deferred stock units.
F3: At the Effective Time of the Merger, all restricted stock units of the Issuer automatically vested and were automatically converted into United restricted stock units calculated by taking the merger consideration of $25.75 per share of Common Stock of the Issuer and dividing it by the Equity Award Exchange Ratio and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer restricted stock units.
F4: These options are fully vested.
F5: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option.
F6: These stock appreciation rights ("SARs") are fully vested. Pursuant to the Merger Agreement, the SARs were automatically converted into SARs of UnitedHealth Group, denominated in a number of shares of common stock of UnitedHealth Group equal to the product of the number of shares of Common Stock subject to the Issuer SARs multiplied by the Equity Award Exchange Ratio, at an exercise price per share equal to the strike price per share applicable to such SAR divided by the Equity Award Exchange Ratio. The UnitedHealth Group SARs will continue to be subject to the same terms and conditions as were applicable to the Issuer SARs.
Summit Materials, Inc.
Report date February 10, 2025 · Filed February 10, 2025
Section 16 reporting ended · disclosed 2025-02-10. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-02-10 transaction · row 1
1 source rowRow 1 · 2025-02-10 · Disposition to issuer · Disposed 62,135 · Balance 0 F1: At or immediately prior to the effective time of the transactions contemplated by the Agreement and Plan of Merger, dated November 24, 2024, by and among Summit Materials, Inc., Quikrete Holdings, Inc., and Soar Subsidiary, Inc., (i) each share of Class A common stock of the issuer held by the reporting person was canceled, retired and converted into the right to receive $52.50 in cash (the "Merger Consideration"), (ii) each restricted stock unit held by the reporting person was fully vested, canceled and converted into the right to receive the Merger Consideration and (iii) each stock option held by the reporting person was fully vested, canceled and converted into the right to receive an amount equal to the excess of the Merger Consideration over the applicable exercise price. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-02-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-02-10 · Disposition to issuer · Disposed 3,341 · Balance 0 F1: At or immediately prior to the effective time of the transactions contemplated by the Agreement and Plan of Merger, dated November 24, 2024, by and among Summit Materials, Inc., Quikrete Holdings, Inc., and Soar Subsidiary, Inc., (i) each share of Class A common stock of the issuer held by the reporting person was canceled, retired and converted into the right to receive $52.50 in cash (the "Merger Consideration"), (ii) each restricted stock unit held by the reporting person was fully vested, canceled and converted into the right to receive the Merger Consideration and (iii) each stock option held by the reporting person was fully vested, canceled and converted into the right to receive an amount equal to the excess of the Merger Consideration over the applicable exercise price. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-02-10 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-02-10 · Disposition to issuer · Disposed 2,547 · Balance 0 F1: At or immediately prior to the effective time of the transactions contemplated by the Agreement and Plan of Merger, dated November 24, 2024, by and among Summit Materials, Inc., Quikrete Holdings, Inc., and Soar Subsidiary, Inc., (i) each share of Class A common stock of the issuer held by the reporting person was canceled, retired and converted into the right to receive $52.50 in cash (the "Merger Consideration"), (ii) each restricted stock unit held by the reporting person was fully vested, canceled and converted into the right to receive the Merger Consideration and (iii) each stock option held by the reporting person was fully vested, canceled and converted into the right to receive an amount equal to the excess of the Merger Consideration over the applicable exercise price. |
| Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.00 | Direct | 0 |
Reported balance
After 2025-02-10 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-02-10 · Disposition to issuer · Disposed 81,611 · Balance 0 F1: At or immediately prior to the effective time of the transactions contemplated by the Agreement and Plan of Merger, dated November 24, 2024, by and among Summit Materials, Inc., Quikrete Holdings, Inc., and Soar Subsidiary, Inc., (i) each share of Class A common stock of the issuer held by the reporting person was canceled, retired and converted into the right to receive $52.50 in cash (the "Merger Consideration"), (ii) each restricted stock unit held by the reporting person was fully vested, canceled and converted into the right to receive the Merger Consideration and (iii) each stock option held by the reporting person was fully vested, canceled and converted into the right to receive an amount equal to the excess of the Merger Consideration over the applicable exercise price. |
Filing footnotes · ownership attribution and instrument terms
F1: At or immediately prior to the effective time of the transactions contemplated by the Agreement and Plan of Merger, dated November 24, 2024, by and among Summit Materials, Inc., Quikrete Holdings, Inc., and Soar Subsidiary, Inc., (i) each share of Class A common stock of the issuer held by the reporting person was canceled, retired and converted into the right to receive $52.50 in cash (the "Merger Consideration"), (ii) each restricted stock unit held by the reporting person was fully vested, canceled and converted into the right to receive the Merger Consideration and (iii) each stock option held by the reporting person was fully vested, canceled and converted into the right to receive an amount equal to the excess of the Merger Consideration over the applicable exercise price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 18, 2021 Filed Mar 22, 2021 21:23 UTC | Summit Materials, Inc. SUM · Entity 16259 | SaleClass A Common Stock | 23,997 | $27.65 | $663,517.05 |
DisclosureSEC source: 0001104659-21-039884 · tm2110456d2_4seq1.xml · nonDerivative · entry 1 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,083 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.43 to $27.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The Reporting Person remains within compliance of the Issuer's equity ownership guidelines. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 19:27 UTC | Summit Materials, Inc. SUM · Entity 16259 | Exercise / conversionRestricted Stock Units · Derivative | 5,342 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-030934 · a4.xml · derivative · entry 2 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 5,342 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock. The restricted stock units will be settled in either Class A Common Stock or cash (or a combination thereof) at the discretion of the Issuer's compensation committee. F3 · derivative.exercise_date: On February 28, 2020, the Reporting Person was granted 5,342 restricted stock units that vested on February 28, 2021. F3 · derivative.expiration_date: On February 28, 2020, the Reporting Person was granted 5,342 restricted stock units that vested on February 28, 2021. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 19:27 UTC | Summit Materials, Inc. SUM · Entity 16259 | Exercise / conversionClass A Common Stock | 5,342 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-030934 · a4.xml · nonDerivative · entry 1 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects restricted stock units that upon vesting converted into shares of Class A common stock of the Issuer ("Class A Common Stock") on a one-for-one basis. Read SEC document |
| June 17, 2020 Filed Jun 19, 2020 20:38 UTC | Change Healthcare Inc. CHNG · Entity 15437 | GrantCommon Stock | 14,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-20-002926 · form4.xml · nonDerivative · entry 1 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,720 F1 · shares: Represents a grant of restricted stock units that vests on June 17, 2021. Read SEC document |
| May 01, 2020 Filed May 5, 2020 22:07 UTC | Change Healthcare Inc. CHNG · Entity 15437 | GrantStock Appreciation Right · Derivative | 34,319 | Not disclosed Strike: $0.38 | Not disclosed |
DisclosureSEC source: 0000899243-20-012083 · doc4.xml · derivative · entry 2 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,319 Underlying: Common Stock · 34,319 shares Expires 2023-05-22 F1 · kind: On May 1, 2020, pursuant to a Merger Agreement, dated as of April 30, 2020, entered into by and among Change Healthcare Solutions, LLC, a wholly owned subsidiary of the Issuer (the "Purchaser"), Change Healthcare Solutions MergerCo Inc., a wholly owned subsidiary of the Purchaser (the "Merger Sub"), eRx Network Holdings, Inc. (the "Target"), and other parties thereto, Merger Sub merged with and into Target, with Target being the surviving entity of such merger and becoming a wholly owned subsidiary of Purchaser (the "Merger"). In connection with the Merger, pursuant to a rollover arrangement with the Issuer, certain of the Reporting Person's equity awards of Target converted into equity awards of the Issuer. F1 · price: On May 1, 2020, pursuant to a Merger Agreement, dated as of April 30, 2020, entered into by and among Change Healthcare Solutions, LLC, a wholly owned subsidiary of the Issuer (the "Purchaser"), Change Healthcare Solutions MergerCo Inc., a wholly owned subsidiary of the Purchaser (the "Merger Sub"), eRx Network Holdings, Inc. (the "Target"), and other parties thereto, Merger Sub merged with and into Target, with Target being the surviving entity of such merger and becoming a wholly owned subsidiary of Purchaser (the "Merger"). In connection with the Merger, pursuant to a rollover arrangement with the Issuer, certain of the Reporting Person's equity awards of Target converted into equity awards of the Issuer. F2 · derivative.exercise_date: These stock appreciation rights are fully vested. Read SEC document |
| May 01, 2020 Filed May 5, 2020 22:07 UTC | Change Healthcare Inc. CHNG · Entity 15437 | GrantStock Appreciation Right · Derivative | 11,439 | Not disclosed Strike: $0.38 | Not disclosed |
DisclosureSEC source: 0000899243-20-012083 · doc4.xml · derivative · entry 1 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,439 Underlying: Common Stock · 11,439 shares Expires 2022-11-28 F1 · kind: On May 1, 2020, pursuant to a Merger Agreement, dated as of April 30, 2020, entered into by and among Change Healthcare Solutions, LLC, a wholly owned subsidiary of the Issuer (the "Purchaser"), Change Healthcare Solutions MergerCo Inc., a wholly owned subsidiary of the Purchaser (the "Merger Sub"), eRx Network Holdings, Inc. (the "Target"), and other parties thereto, Merger Sub merged with and into Target, with Target being the surviving entity of such merger and becoming a wholly owned subsidiary of Purchaser (the "Merger"). In connection with the Merger, pursuant to a rollover arrangement with the Issuer, certain of the Reporting Person's equity awards of Target converted into equity awards of the Issuer. F1 · price: On May 1, 2020, pursuant to a Merger Agreement, dated as of April 30, 2020, entered into by and among Change Healthcare Solutions, LLC, a wholly owned subsidiary of the Issuer (the "Purchaser"), Change Healthcare Solutions MergerCo Inc., a wholly owned subsidiary of the Purchaser (the "Merger Sub"), eRx Network Holdings, Inc. (the "Target"), and other parties thereto, Merger Sub merged with and into Target, with Target being the surviving entity of such merger and becoming a wholly owned subsidiary of Purchaser (the "Merger"). In connection with the Merger, pursuant to a rollover arrangement with the Issuer, certain of the Reporting Person's equity awards of Target converted into equity awards of the Issuer. F2 · derivative.exercise_date: These stock appreciation rights are fully vested. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:41 UTC | Summit Materials, Inc. SUM · Entity 16259 | GrantRestricted Stock Units · Derivative | 5,342 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-028860 · a4.xml · derivative · entry 3 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,342 Underlying: Class A Common Stock · 5,342 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock. The restricted stock units will be settled in either Class A Common Stock or cash (or a combination thereof) at the discretion of the Issuer's compensation committee. F4 · derivative.exercise_date: These restricted stock units vest on February 28, 2021. F4 · derivative.expiration_date: These restricted stock units vest on February 28, 2021. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:41 UTC | Summit Materials, Inc. SUM · Entity 16259 | Exercise / conversionRestricted Stock Units · Derivative | 8,143 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-028860 · a4.xml · derivative · entry 2 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 8,143 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock. The restricted stock units will be settled in either Class A Common Stock or cash (or a combination thereof) at the discretion of the Issuer's compensation committee. F3 · derivative.exercise_date: On February 28, 2019, the Reporting Person was granted 8,143 restricted stock units that vested on February 28, 2020. F3 · derivative.expiration_date: On February 28, 2019, the Reporting Person was granted 8,143 restricted stock units that vested on February 28, 2020. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:41 UTC | Summit Materials, Inc. SUM · Entity 16259 | Exercise / conversionClass A Common Stock | 8,143 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-028860 · a4.xml · nonDerivative · entry 1 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,738 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects restricted stock units that upon vesting converted into shares of Class A common stock of the Issuer ("Class A Common Stock") on a one-for-one basis. Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 21:23 UTC | Change Healthcare Inc. CHNG · Entity 15437 | GrantCommon Stock | 11,426 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-022311 · doc4.xml · nonDerivative · entry 1 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,234 F1 · shares: Represents a grant of restricted stock units that vests on August 1, 2020. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 18:03 UTC | Summit Materials, Inc. SUM · Entity 16259 | GrantRestricted Stock Units · Derivative | 8,143 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-012129 · a4.xml · derivative · entry 3 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,143 Underlying: Class A Common Stock · 8,143 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock. The restricted stock units will be settled in either Class A Common Stock or cash (or a combination thereof) at the discretion of the Issuer's compensation committee. F4 · derivative.exercise_date: These restricted stock units vest on February 28, 2020. F4 · derivative.expiration_date: These restricted stock units vest on February 28, 2020. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 18:03 UTC | Summit Materials, Inc. SUM · Entity 16259 | Exercise / conversionRestricted Stock Units · Derivative | 3,994 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-012129 · a4.xml · derivative · entry 2 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 3,994 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock. The restricted stock units will be settled in either Class A Common Stock or cash (or a combination thereof) at the discretion of the Issuer's compensation committee. F3 · derivative.exercise_date: On February 28, 2018, the Reporting Person was granted 3,994 restricted stock units that vested on February 28, 2019. F3 · derivative.expiration_date: On February 28, 2018, the Reporting Person was granted 3,994 restricted stock units that vested on February 28, 2019. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 18:03 UTC | Summit Materials, Inc. SUM · Entity 16259 | Exercise / conversionClass A Common Stock | 3,994 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-19-012129 · a4.xml · nonDerivative · entry 1 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects restricted stock units that upon vesting converted into shares of Class A common stock of the Issuer ("Class A Common Stock") on a one-for-one basis. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 20:56 UTC | Summit Materials, Inc. SUM · Entity 16259 | GrantRestricted Stock Units · Derivative | 3,994 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-014201 · a4.xml · derivative · entry 3 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,994 Underlying: Class A Common Stock · 3,994 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock. The restricted stock units will be settled in either Class A Common Stock or cash (or a combination thereof) at the discretion of the Issuer's compensation committee. F5 · derivative.exercise_date: These restricted stock units vest on February 28, 2019. F5 · derivative.expiration_date: These restricted stock units vest on February 28, 2019. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 20:56 UTC | Summit Materials, Inc. SUM · Entity 16259 | Exercise / conversionRestricted Stock Units · Derivative | 4,098 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-014201 · a4.xml · derivative · entry 2 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 4,098 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock. The restricted stock units will be settled in either Class A Common Stock or cash (or a combination thereof) at the discretion of the Issuer's compensation committee. F4 · derivative.exercise_date: On February 28, 2017, the Reporting Person was granted 4,098 restricted stock units that vested on February 28, 2018. F4 · derivative.expiration_date: On February 28, 2017, the Reporting Person was granted 4,098 restricted stock units that vested on February 28, 2018. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 20:56 UTC | Summit Materials, Inc. SUM · Entity 16259 | Exercise / conversionClass A Common Stock | 4,098 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-18-014201 · a4.xml · nonDerivative · entry 1 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,601 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects restricted stock units that upon vesting converted into shares of Class A common stock of the Issuer ("Class A Common Stock") on a one-for-one basis. F2 · balance_after: Total holdings include shares of Class A Common Stock received pursuant to a stock dividend paid on December 22, 2017. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 20:18 UTC | Summit Materials, Inc. SUM · Entity 16259 | GrantRestricted Stock Units · Derivative | 4,098 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-17-013642 · a4.xml · derivative · entry 1 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,098 Underlying: Class A Common Stock · 4,098 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock ("Class A Common Stock"). The restricted stock units will be settled in either Class A Common Stock or cash (or a combination thereof) at the discretion of the Issuer's compensation committee. F2 · derivative.exercise_date: The restricted stock units vest on February 28, 2018. F2 · derivative.expiration_date: The restricted stock units vest on February 28, 2018. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 20:15 UTC | Summit Materials, Inc. SUM · Entity 16259 | Exercise / conversionRestricted Stock Units · Derivative | 6,414 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-17-012714 · a4.xml · derivative · entry 2 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 6,414 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock. The restricted stock units settle in either Class A Common Stock or cash (or a combination thereof) at the discretion of the Issuer's compensation committee. F3 · derivative.exercise_date: On February 24, 2016, the Reporting Person was granted 6,414 restricted stock units that vested on February 24, 2017. F3 · derivative.expiration_date: On February 24, 2016, the Reporting Person was granted 6,414 restricted stock units that vested on February 24, 2017. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 20:15 UTC | Summit Materials, Inc. SUM · Entity 16259 | Exercise / conversionClass A Common Stock | 6,414 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-17-012714 · a4.xml · nonDerivative · entry 1 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,414 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects restricted stock units that upon vesting converted into shares of Class A common stock of the Issuer ("Class A Common Stock") on a one-for-one basis. Read SEC document |
| November 16, 2016 Filed Nov 18, 2016 18:00 UTC | Summit Materials, Inc. SUM · Entity 16259 | ConversionLP Units of Summit Materials Holdings L.P. · Derivative | 15,727 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-16-158177 · a4.xml · derivative · entry 3 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,772 Underlying: Class A Common Stock · 15,727 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Pursuant to the terms of an exchange agreement, dated as of March 11, 2015, the limited partnership units of Summit Materials Holdings L.P. ("LP Units") reported herein are exchangeable from and after the first anniversary of the closing of the issuer's initial public offering (subject to the terms of the exchange agreement and vesting requirements, including certain vesting events more fully described in the issuer's Registration Statement on Form S-1 (File No. 333-201058)) for shares of the issuer's Class A common stock ("Class A Common Stock") on a one-for-one basis. F1 · price: Pursuant to the terms of an exchange agreement, dated as of March 11, 2015, the limited partnership units of Summit Materials Holdings L.P. ("LP Units") reported herein are exchangeable from and after the first anniversary of the closing of the issuer's initial public offering (subject to the terms of the exchange agreement and vesting requirements, including certain vesting events more fully described in the issuer's Registration Statement on Form S-1 (File No. 333-201058)) for shares of the issuer's Class A common stock ("Class A Common Stock") on a one-for-one basis. F1 · derivative.exercise_date: Pursuant to the terms of an exchange agreement, dated as of March 11, 2015, the limited partnership units of Summit Materials Holdings L.P. ("LP Units") reported herein are exchangeable from and after the first anniversary of the closing of the issuer's initial public offering (subject to the terms of the exchange agreement and vesting requirements, including certain vesting events more fully described in the issuer's Registration Statement on Form S-1 (File No. 333-201058)) for shares of the issuer's Class A common stock ("Class A Common Stock") on a one-for-one basis. F1 · derivative.expiration_date: Pursuant to the terms of an exchange agreement, dated as of March 11, 2015, the limited partnership units of Summit Materials Holdings L.P. ("LP Units") reported herein are exchangeable from and after the first anniversary of the closing of the issuer's initial public offering (subject to the terms of the exchange agreement and vesting requirements, including certain vesting events more fully described in the issuer's Registration Statement on Form S-1 (File No. 333-201058)) for shares of the issuer's Class A common stock ("Class A Common Stock") on a one-for-one basis. Read SEC document |
| November 16, 2016 Filed Nov 18, 2016 18:00 UTC | Summit Materials, Inc. SUM · Entity 16259 | SaleClass A Common Stock | 15,727 | $21.87 | $343,949.49 |
DisclosureSEC source: 0001104659-16-158177 · a4.xml · nonDerivative · entry 2 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: This amount represents the $22.10 public offering price per share of Class A Common Stock, less the underwriting discount of $0.23 per share. Read SEC document |
| November 16, 2016 Filed Nov 18, 2016 18:00 UTC | Summit Materials, Inc. SUM · Entity 16259 | ConversionClass A Common Stock | 15,727 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-16-158177 · a4.xml · nonDerivative · entry 1 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,727 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Pursuant to the terms of an exchange agreement, dated as of March 11, 2015, the limited partnership units of Summit Materials Holdings L.P. ("LP Units") reported herein are exchangeable from and after the first anniversary of the closing of the issuer's initial public offering (subject to the terms of the exchange agreement and vesting requirements, including certain vesting events more fully described in the issuer's Registration Statement on Form S-1 (File No. 333-201058)) for shares of the issuer's Class A common stock ("Class A Common Stock") on a one-for-one basis. Read SEC document |
| March 21, 2014 Filed Mar 21, 2014 12:08 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock · Derivative | 1,380 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-14-000068 · edgar.xml · derivative · entry 2 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,380 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On March 21, 2014, 1,380 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F1 · price: On March 21, 2014, 1,380 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.exercise_date: On March 21, 2014, 1,380 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.expiration_date: On March 21, 2014, 1,380 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| March 21, 2014 Filed Mar 21, 2014 12:08 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 1,380 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-14-000068 · edgar.xml · nonDerivative · entry 1 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,519 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On March 21, 2014, 1,380 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| March 12, 2014 Filed Mar 7, 2014 23:01 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionStock Option granted 02/13/2013 (right to buy) · Derivative | 1,104 | $64.01 Strike: $64.01 | $70,667.04 |
DisclosureSEC source: 0000310764-14-000052 · edgar.xml · derivative · entry 15 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,416 Underlying: Common Stock · 1,104 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Stock option granted pursuant to the Stryker Corporation 2006 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| March 12, 2014 Filed Mar 7, 2014 23:01 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionStock Option granted 02/21/2012 (right to buy) · Derivative | 1,978 | $53.60 Strike: $53.60 | $106,020.80 |
DisclosureSEC source: 0000310764-14-000052 · edgar.xml · derivative · entry 14 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,967 Underlying: Common Stock · 1,978 shares Expires 2022-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Stock option granted pursuant to the Stryker Corporation 2006 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| March 12, 2014 Filed Mar 7, 2014 23:01 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionStock Option granted 02/09/2011 (right to buy) · Derivative | 2,841 | $59.70 Strike: $59.70 | $169,607.70 |
DisclosureSEC source: 0000310764-14-000052 · edgar.xml · derivative · entry 13 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,894 Underlying: Common Stock · 2,841 shares Expires 2021-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Stock option granted pursuant to the Stryker Corporation 2006 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| March 12, 2014 Filed Mar 7, 2014 23:01 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionStock Option granted 02/23/2010 (right to buy) · Derivative | 7,996 | $53.09 Strike: $53.09 | $424,507.64 |
DisclosureSEC source: 0000310764-14-000052 · edgar.xml · derivative · entry 12 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,999 Underlying: Common Stock · 7,996 shares Expires 2020-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Stock option granted pursuant to the Stryker Corporation 2006 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| March 12, 2014 Filed Mar 7, 2014 23:01 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionStock Option granted 04/29/2009 (right to buy) · Derivative | 11,000 | $37.86 Strike: $37.86 | $416,460.00 |
DisclosureSEC source: 0000310764-14-000052 · edgar.xml · derivative · entry 11 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,750 Underlying: Common Stock · 11,000 shares Expires 2019-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Stock option granted pursuant to the Stryker Corporation 2006 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| March 12, 2014 Filed Mar 7, 2014 23:01 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 864 | $81.87 | $70,735.68 |
DisclosureSEC source: 0000310764-14-000052 · edgar.xml · nonDerivative · entry 10 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,139 F5 · shares: 864 shares were withheld to cover the option cost. Read SEC document |
| March 12, 2014 Filed Mar 7, 2014 23:01 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 1,104 | $64.01 | $70,667.04 |
DisclosureSEC source: 0000310764-14-000052 · edgar.xml · nonDerivative · entry 9 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,003 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2014 Filed Mar 7, 2014 23:01 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 1,295 | $81.87 | $106,021.65 |
DisclosureSEC source: 0000310764-14-000052 · edgar.xml · nonDerivative · entry 8 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,899 F4 · shares: 1,295 shares were withheld to cover the option cost. Read SEC document |
| March 12, 2014 Filed Mar 7, 2014 23:01 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 1,978 | $53.60 | $106,020.80 |
DisclosureSEC source: 0000310764-14-000052 · edgar.xml · nonDerivative · entry 7 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,194 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2014 Filed Mar 7, 2014 23:01 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 2,072 | $81.87 | $169,634.64 |
DisclosureSEC source: 0000310764-14-000052 · edgar.xml · nonDerivative · entry 6 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,216 F3 · shares: 2,072 shares were withheld to cover the option cost. Read SEC document |
| March 12, 2014 Filed Mar 7, 2014 23:01 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 2,841 | $59.70 | $169,607.70 |
DisclosureSEC source: 0000310764-14-000052 · edgar.xml · nonDerivative · entry 5 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,288 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2014 Filed Mar 7, 2014 23:01 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 5,186 | $81.87 | $424,577.82 |
DisclosureSEC source: 0000310764-14-000052 · edgar.xml · nonDerivative · entry 4 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,447 F2 · shares: 5,186 shares were withheld to cover the option cost. Read SEC document |
| March 12, 2014 Filed Mar 7, 2014 23:01 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 7,996 | $53.09 | $424,507.64 |
DisclosureSEC source: 0000310764-14-000052 · edgar.xml · nonDerivative · entry 3 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,633 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2014 Filed Mar 7, 2014 23:01 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 5,087 | $81.87 | $416,472.69 |
DisclosureSEC source: 0000310764-14-000052 · edgar.xml · nonDerivative · entry 2 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,637 F1 · shares: 5,087 shares were withheld to cover the option cost. Read SEC document |
| March 12, 2014 Filed Mar 7, 2014 23:01 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 11,000 | $37.86 | $416,460.00 |
DisclosureSEC source: 0000310764-14-000052 · edgar.xml · nonDerivative · entry 1 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,724 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2014 Filed Feb 14, 2014 20:14 UTC | STRYKER CORP SYK · Entity 369 | GrantRestricted Stock Units granted 02/12/2014 · Derivative | 1,089 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-14-000032 · edgar.xml · derivative · entry 2 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,089 Underlying: Common Stock · 1,089 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Stryker Common Stock. F2 · price: Each restricted stock unit represents a contingent right to receive one share of Stryker Common Stock. F3 · derivative.exercise_date: The restricted stock units vest as to 100% of the shares on March 21, 2015. F3 · derivative.expiration_date: The restricted stock units vest as to 100% of the shares on March 21, 2015. Read SEC document |
| February 12, 2014 Filed Feb 14, 2014 20:14 UTC | STRYKER CORP SYK · Entity 369 | GrantStock Option granted 02/12/2014 (right to buy) · Derivative | 4,355 | $0.00 Strike: $81.14 | $0.00 |
DisclosureSEC source: 0000310764-14-000032 · edgar.xml · derivative · entry 1 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,355 Underlying: Common Stock · 4,355 shares Expires 2024-02-11 F1 · derivative.exercise_date: Stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| March 21, 2013 Filed Mar 25, 2013 21:00 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock · Derivative | 1,647 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-13-000070 · edgar.xml · derivative · entry 2 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,647 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On March 21, 2013, 1,647 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F1 · price: On March 21, 2013, 1,647 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.exercise_date: On March 21, 2013, 1,647 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.expiration_date: On March 21, 2013, 1,647 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| March 21, 2013 Filed Mar 25, 2013 21:00 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 1,647 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-13-000070 · edgar.xml · nonDerivative · entry 1 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,724 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On March 21, 2013, 1,647 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F2 · balance_after: Since the date of the reporting person's last ownership report, he transferred 4,501 shares of Stryker Common Stock to his ex-wife pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by his ex-wife. Read SEC document |
| February 13, 2013 Filed Feb 15, 2013 23:00 UTC | STRYKER CORP SYK · Entity 369 | GrantRestricted Stock Units granted 02/13/2013 · Derivative | 1,380 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-13-000039 · edgar.xml · derivative · entry 2 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,380 Underlying: Common Stock · 1,380 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Stryker Common Stock. F2 · price: Each restricted stock unit represents a contingent right to receive one share of Stryker Common Stock. F3 · derivative.exercise_date: The restricted stock units vest as to 100% of the shares on March 21, 2014. Vesting will be accelerated in the event of termination of service as a Director of Stryker by reason of disability or death but will otherwise cease upon termination of service as a Director of Stryker. F3 · derivative.expiration_date: The restricted stock units vest as to 100% of the shares on March 21, 2014. Vesting will be accelerated in the event of termination of service as a Director of Stryker by reason of disability or death but will otherwise cease upon termination of service as a Director of Stryker. Read SEC document |
| February 13, 2013 Filed Feb 15, 2013 23:00 UTC | STRYKER CORP SYK · Entity 369 | GrantStock Option granted 02/13/2013 (right to buy) · Derivative | 5,520 | $64.01 Strike: $64.01 | $353,335.20 |
DisclosureSEC source: 0000310764-13-000039 · edgar.xml · derivative · entry 1 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,520 Underlying: Common Stock · 5,520 shares Expires 2023-02-12 F1 · derivative.exercise_date: Stock option granted pursuant to the Stryker Corporation 2006 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| March 21, 2012 Filed Mar 23, 2012 20:23 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock · Derivative | 1,578 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-12-000103 · edgar.xml · derivative · entry 2 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,578 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On March 21, 2012, 1,578 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F1 · price: On March 21, 2012, 1,578 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.exercise_date: On March 21, 2012, 1,578 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.expiration_date: On March 21, 2012, 1,578 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| March 21, 2012 Filed Mar 23, 2012 20:23 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 1,578 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-12-000103 · edgar.xml · nonDerivative · entry 1 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,578 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On March 21, 2012, 1,578 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| February 21, 2012 Filed Feb 24, 2012 01:29 UTC | STRYKER CORP SYK · Entity 369 | GrantCommon Stock · Derivative | 1,647 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-12-000074 · edgar.xml · derivative · entry 2 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,647 Underlying: Common Stock · 1,647 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Stryker Common Stock. F3 · derivative.exercise_date: The restricted stock units vest as to 100% of the shares on February 21, 2013. Vesting will be accelerated in the event of termination of service as a Director of Stryker by reason of disability or death but will otherwise cease upon termination of service as a Director of Stryker. F3 · derivative.expiration_date: The restricted stock units vest as to 100% of the shares on February 21, 2013. Vesting will be accelerated in the event of termination of service as a Director of Stryker by reason of disability or death but will otherwise cease upon termination of service as a Director of Stryker. Read SEC document |
| February 21, 2012 Filed Feb 24, 2012 01:29 UTC | STRYKER CORP SYK · Entity 369 | GrantCommon Stock · Derivative | 4,945 | $53.60 Strike: $53.60 | $265,052.00 |
DisclosureSEC source: 0000310764-12-000074 · edgar.xml · derivative · entry 1 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,945 Underlying: Common Stock · 4,945 shares Expires 2022-02-20 F1 · derivative.exercise_date: Stock option granted pursuant to the Stryker Corporation 2006 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| February 21, 2012 Filed Feb 15, 2013 23:04 UTC | STRYKER CORP SYK · Entity 369 | GrantCommon Stock · Derivative | 1,647 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-13-000040 · edgar.xml · derivative · entry 2 LANCE HOWARD L · CIK 0001220679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,647 Underlying: Common Stock · 1,647 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Stryker Common Stock. F3 · derivative.exercise_date: The restricted stock units vest as to 100% of the shares on February 21, 2013. Vesting will be accelerated in the event of termination of service as a Director of Stryker by reason of disability or death but will otherwise cease upon termination of service as a Director of Stryker. F3 · derivative.expiration_date: The restricted stock units vest as to 100% of the shares on February 21, 2013. Vesting will be accelerated in the event of termination of service as a Director of Stryker by reason of disability or death but will otherwise cease upon termination of service as a Director of Stryker. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.